Considering that the stock has dropped about 50 percent from its all time high, I personally believe it's currently significantly underpriced and a great buy. Yes, the company still has no product out, but it's getting there. If Phase 3 trials work out, this could explode. We all know obesity will always need more solutions.
There are no replies in this thread yet. Be the first to post a reply below: